Sign in Register

MR-Guided Focused Ultrasound Neuromodulation of Nucleus Accumbens to Attenuate Oral Fentanyl Motivation in A Self-Administration Rat Model.

By Martin DA, Eldirdiri A, Ernst T, Cunningham E, Bernard S, Kamdi S, Calu DJ, Chang L · · 1 min read

Save

Introduction: Transcranial low-intensity focused ultrasound (LIFU) is being explored as a non-invasive approach for neuromodulation to treat opioid use disorder (OUD). Methods: We evaluated MR-guided focused ultrasound, with LIFU, targeting nucleus accumbens (MRgLIFU-NAc) bilaterally, using MR-acoustic radiation force-imaging (MR-ARFI) to ensure accurate targeting and adjust for FUS intensity delivered at the target. Male and female rats were trained to self-administer fentanyl/sucrose (70ug/ml fentanyl citrate in 5% sucrose) or 5% sucrose alone.

Three cohorts of rats (total n=76) were evaluated on progressive ratio (PR) responding for oral fentanyl/sucrose at either 4 or 24 hours post-MRgLIFU-NAc. Animals in the first two cohorts received repeated rounds of LIFU or sham (anesthesia-duration matched). In cohort 3, we used a counterbalanced within-subjects design in which rats received both LIFU and sham one week apart.

Results: Reducing sucrose concentrations decreased responding for sucrose alone more than for fentanyl/sucrose, demonstrating a role for fentanyl in the reinforcing properties of fentanyl/sucrose. Across three sonication schemes, MRgLIFU-NAc did not attenuate PR performance for oral fentanyl/sucrose at 4 or 24-hours post-LIFU relative to controls. Adjusting LIFU intensity with MR-ARFI did not correlate with changes in PR from baseline.

We confirmed that NAc is the correct target by bilateral inactivation of NAc with muscimol/baclofen mixture (50 + 50 ng/side), which reduced PR responding for fentanyl/sucrose. Conclusion: The three sets of LIFU parameters, with repeated MRgLIFU-NAc sessions, did not produce detectable changes in oral fentanyl/sucrose motivation. Further studies are required to determine effective LIFU parameters needed to reduce NAc-dependent fentanyl motivation.

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.

Related articles

PubMed

Development of novel Mu opioid receptor antagonists based on a 6,4-spiro bicyclic fentanyl-derived scaffold.

Scaffold reorganization represents a strategy for modulating Mu opioid receptor (MOR) signaling within flexible opioid scaffolds. Herein, a 6,4-spiro bicyclic core derived from the fentanyl framework was adopted to reduce conformational flexibility while preserving key pharmacophoric features of the parent 8-membered scaffold. Biological evaluations identified compound 3, bearing 2-furanyl and cyclobutylmethyl substituents, as the most potent analogue in this series. Compound 3 exhibited MOR bin...

PubMed

Separate and concurrent use of methamphetamine and fentanyl: behavioral and neurobiological consequences.

Background Methamphetamine, a potent psychostimulant, is one of the most used substances globally. When administered alone, methamphetamine has powerful rewarding and reinforcing properties and produces numerous health consequences. However, recent national trends reveal that methamphetamine is increasingly being used concurrently with fentanyl. Of particular concern is that many methamphetamine users are unwittingly exposed to fentanyl, due to the increasing rate at which psychostimulants are...